| Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
| 08/05/2024 | 23:00 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NYSE:ABT | Abbott Laboratories |
| 08/05/2024 | 00:59 | Edgar (US Regulatory) | Form 144 - Report of proposed sale of securities | NYSE:ABT | Abbott Laboratories |
| 29/04/2024 | 15:00 | PR Newswire (US) | Abbott's Breakthrough Dissolving Stent Receives FDA Approval for Arteries Below the Knee | NYSE:ABT | Abbott Laboratories |
| 17/04/2024 | 17:37 | IH Market News | Abbott Laboratories Reports Strong Q1 Sales Growth Amid Earnings Decline, Raises Full-Year Guidance | NYSE:ABT | Abbott Laboratories |
| 17/04/2024 | 13:30 | PR Newswire (US) | Abbott Reports First-Quarter 2024 Results and Raises Midpoint of Full-Year Guidance Ranges | NYSE:ABT | Abbott Laboratories |
| 17/04/2024 | 12:59 | IH Market News | US Index Futures See Gains, Oil Prices Dip | NYSE:ABT | Abbott Laboratories |
| 03/04/2024 | 13:12 | IH Market News | Cal-Maine Surges on Strong Quarterly Performance, Taiwan Earthquake Disrupts Tech Supply Chain, and More | NYSE:ABT | Abbott Laboratories |
| 02/04/2024 | 15:00 | PR Newswire (US) | Abbott Receives FDA Approval for TriClip™, First-of-Its-Kind Device to Repair Leaky Tricuspid Heart Valve | NYSE:ABT | Abbott Laboratories |
| 01/04/2024 | 15:00 | PR Newswire (US) | Abbott Receives FDA Clearance for Whole Blood Rapid Test to Help with Assessment of Concussion at the Patient's Bedside | NYSE:ABT | Abbott Laboratories |
| 27/03/2024 | 21:30 | PR Newswire (US) | Abbott Hosts Conference Call for First-Quarter Earnings | NYSE:ABT | Abbott Laboratories |
| 19/03/2024 | 13:00 | PR Newswire (Canada) | Canadian First - Abbott Advances Chronic Pain Management with the World's Smallest Implanted, Rechargeable Spinal Cord Stimulation System | NYSE:ABT | Abbott Laboratories |
| 19/03/2024 | 13:00 | PR Newswire (Canada) | Une première au Canada -- Abbott fait progresser le traitement de la douleur chronique grâce au plus petit système de stimulation de la moelle épinière implantée et rechargeable au monde | NYSE:ABT | Abbott Laboratories |
| 06/03/2024 | 15:00 | PR Newswire (US) | Real-World Data Show Abbott's FreeStyle Libre® Systems and GLP-1 Medicines Work Better Together for People with Type 2 Diabetes | NYSE:ABT | Abbott Laboratories |
| 16/02/2024 | 22:15 | Edgar (US Regulatory) | Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] | NYSE:ABT | Abbott Laboratories |
| 16/02/2024 | 16:19 | PR Newswire (US) | Abbott Declares 401st Consecutive Quarterly Dividend | NYSE:ABT | Abbott Laboratories |
| 14/02/2024 | 00:47 | PR Newswire (US) | FDA Advisory Committee Votes in Favor of Abbott's First-of-Its-Kind TriClip™ System to Treat People With a Leaky Tricuspid Heart Valve | NYSE:ABT | Abbott Laboratories |
| 13/02/2024 | 22:55 | Edgar (US Regulatory) | Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] | NYSE:ABT | Abbott Laboratories |
| 05/02/2024 | 11:31 | IH Market News | Santander’s Stock Declines Amid Sanctions Evasion Scandal, Boeing 737 MAX Delivery Challenges, and More | NYSE:ABT | Abbott Laboratories |
| 01/02/2024 | 15:00 | PR Newswire (US) | New Study Shows Mixed Reality Technology for Blood Donation from Abbott and Blood Centers of America Helps Ease Stress, Encourages People to Donate Again | NYSE:ABT | Abbott Laboratories |
| 31/01/2024 | 15:00 | PR Newswire (US) | Abbott Launches New PROTALITY™ Brand to Support Adults on Their Weight Loss Journey | NYSE:ABT | Abbott Laboratories |
| 29/01/2024 | 22:10 | Edgar (US Regulatory) | Form 8-K - Current report | NYSE:ABT | Abbott Laboratories |
| 25/01/2024 | 15:00 | PR Newswire (US) | Abbott Launches World's Smallest Rechargeable System With Remote Programming Capabilities to Treat Movement Disorders¹+ | NYSE:ABT | Abbott Laboratories |
| 25/01/2024 | 12:25 | IH Market News | Wall Street Highlights: Nokia’s Margins Surprise, FAA Halts Boeing Production Expansion, and More | NYSE:ABT | Abbott Laboratories |
| 24/01/2024 | 14:19 | Dow Jones News | Abbott Labs Posts Higher 4Q Sales, Despite Soft Demand For Covid Tests | NYSE:ABT | Abbott Laboratories |
| 24/01/2024 | 13:30 | PR Newswire (US) | Abbott Reports Fourth-Quarter and Full-Year 2023 Results; Issues 2024 Financial Outlook | NYSE:ABT | Abbott Laboratories |
| 24/01/2024 | 12:06 | IH Market News | Wall Street Highlights: eBay Slashes 9% of Workforce, SAP to Reduce 8,000 Positions, and More | NYSE:ABT | Abbott Laboratories |
| 18/01/2024 | 15:48 | Dow Jones News | Abbott's Volt PFA System Used in Procedures for Patients with Abnormal Heart Rhytms | NYSE:ABT | Abbott Laboratories |
| 18/01/2024 | 15:00 | PR Newswire (US) | Abbott Announces First Global Procedures in a Clinical Trial of its Volt™ Pulsed Field Ablation System to Treat Patients with Abnormal Heart Rhythms | NYSE:ABT | Abbott Laboratories |
| 08/01/2024 | 14:00 | Business Wire | Tandem Diabetes Care’s t:slim X2™ Insulin Pump is the First Automated Insulin Delivery System to Integrate with Abbott’s New FreeStyle Libre® 2 Plus Sensor | NYSE:ABT | Abbott Laboratories |
| 03/01/2024 | 15:00 | PR Newswire (US) | Abbott Hosts Conference Call for Fourth-Quarter Earnings | NYSE:ABT | Abbott Laboratories |